Literature DB >> 12850700

Hepatocellular carcinoma associated with secondary haemochromatosis in non-cirrhotic liver: a case report.

Hobyung Chung1, Masatoshi Kudo, Toshihiko Kawasaki, Masayuki Kitano, Yasunori Minami, Youichirou Suetomi, Hirokazu Onda.   

Abstract

We describe one case of hepatocellular carcinoma (HCC) arising in secondary haemochromatosis in a non-cirrhotic liver. The patient was a 40-year-old male. He had severe pancytopenia due to myelodysplastic syndrome (MDS) and developed secondary haemochromatosis as a result of a large amount of erythrocyte transfusion. Multiple nodules of the liver appeared about 6 years after the diagnosis of MDS. Needle biopsy of the nodules histologically confirmed them to be moderately differentiated HCCs. The liver parenchyma was shown to be non-cirrhotic and a deposit of hemosiderin was also identified, consistent with a finding of haemochromatosis of the liver. Transarterial chemoembolization was performed to treat multiple HCCs. There are a number of reports describing HCC occurrence in non-cirrhotic patients with hereditary haemochromatosis. However, HCC in secondary haemochromatosis without cirrhosis is extremely rare.

Entities:  

Year:  2003        PMID: 12850700     DOI: 10.1016/s1386-6346(03)00109-8

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  7 in total

1.  A Case Report of Hepatocellular Carcinoma in a Non-cirrhotic Patient With Liver Iron Overload Associated With Myelodysplastic Syndrome.

Authors:  Naruhiko Ikoma; Hiroharu Shinozaki; Akihito Kozuki; Sho Ibuki; Kokichi Sugano; Makio Mukai; Yoshihiro Masuda; Kenji Kobayashi; Yoshiro Ogata
Journal:  World J Oncol       Date:  2014-01-16

Review 2.  MRI Appearance of Focal Lesions in Liver Iron Overload.

Authors:  Anna Pecorelli; Paola Franceschi; Lorenzo Braccischi; Federica Izzo; Matteo Renzulli; Rita Golfieri
Journal:  Diagnostics (Basel)       Date:  2022-04-02

Review 3.  Hepatic iron overload and hepatocellular carcinoma.

Authors:  Michael C Kew
Journal:  Liver Cancer       Date:  2014-03       Impact factor: 11.740

Review 4.  MicroRNAs and liver cancer associated with iron overload: therapeutic targets unravelled.

Authors:  Catherine M Greene; Robert B Varley; Matthew W Lawless
Journal:  World J Gastroenterol       Date:  2013-08-28       Impact factor: 5.742

5.  Hepatocellular Carcinoma Arising in a Non-cirrhotic Liver with Secondary Hemochromatosis.

Authors:  Ryo Yamauchi; Kazuhide Takata; Yoshinobu Shinagawa; Takashi Tanaka; Hiromi Fukuda; Sho Fukuda; Hideo Kunimoto; Kaoru Umeda; Daisuke Morihara; Keiji Yokoyama; Yasuaki Takeyama; Makoto Irie; Satoshi Shakado; Mikirou Mizoguchi; Satoshi Hisano; Kengo Yoshimitsu; Shotaro Sakisaka
Journal:  Intern Med       Date:  2018-11-19       Impact factor: 1.271

Review 6.  Iron at the Interface of Hepatocellular Carcinoma.

Authors:  Rossana Paganoni; André Lechel; Maja Vujic Spasic
Journal:  Int J Mol Sci       Date:  2021-04-15       Impact factor: 5.923

Review 7.  Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review.

Authors:  Aakash Desai; Sonia Sandhu; Jin-Ping Lai; Dalbir Singh Sandhu
Journal:  World J Hepatol       Date:  2019-01-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.